Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Tesetaxel is active in patients with gastroesophageal cancer

Jan. 20, 2012

BKM-120 assessed as monotherapy and in combination regimens in metastatic breast cancer

Jan. 11, 2012

New Evestra progesterone receptor inhibitor shows potential as breast cancer therapy

Jan. 10, 2012

Phase I/II data presented on SAR-245408-based combination regimens in metastatic breast cancer

Jan. 10, 2012

Ongoing phase I/II trial assesses combinations of letrozole with SAR-245408 and SAR-245409

Jan. 10, 2012

Phase I/II study evaluates rintatolimod as adjuvant for HER2 vaccine

Jan. 9, 2012

University of Arizona scientists assess natural monoterpene in phase I trial

Jan. 9, 2012

Presurgical trial set to investigate MK-2206 in operable invasive cancer

Jan. 9, 2012

Phase II trial assesses proprietary Exelixis drug in metastatic breast cancer

Jan. 5, 2012

Dual ERK inhibitor shows promise as triple-negative breast cancer therapy

Jan. 5, 2012

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...